• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza A(H7N9) - China - Monitoring human cases (ECDC/CDTR, October 25 2013, edited)

Giuseppe

Emeritus
[Source: European Centre for Disease Prevention and Control (ECDC), full page: (LINK). Edited.]


COMMUNICABLE DISEASE THREATS REPORT, Week 43, 20-26 October 2013

(...)


Influenza A(H7N9) - China - Monitoring human cases

Opening date: 31 March 2013 Latest update: 24 October 2013


Epidemiological summary

On 31 March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus in patients in eastern China.

Since then, 137 cases of human infection with influenza A(H7N9) have been reported from:

  1. Zhejiang (48 cases),
  2. Shanghai (34),
  3. Jiangsu (27),
  4. Henan (4),
  5. Anhui (4),
  6. Beijing (2),
  7. Shandong (2),
  8. Fujian (5),
  9. Hunan (3),
  10. Jiangxi (5),
  11. Hebei (1),
  12. Guangdong (1) and
  13. Taiwan (1).
In addition, the virus has been detected in one asymptomatic case in Beijing. Most cases have developed severe respiratory disease. Forty-five patients have died (case-fatality ratio=33%). The median age is 58 years, ranging between four and 91 years; 39 of 137 patients are female, with gender being unknown in five cases.

A new case was reported on 23 October in a 67 year old male farm worker from Zhejiang Province, with a date of onset on 16 October 2013. He is currently hospitalised. This is the second case reported from Zhejiang province in October 2013.

(?)


ECDC assessment

Influenza A(H7N9) is a zoonotic disease that has spread in poultry in parts of eastern China, causing severe disease in humans. There is no evidence of sustained person-to-person transmission. Close to 3 000 contacts have been followed-up, and only a few are reported to have developed symptoms, as part of three small family clusters. Many unanswered questions remain regarding this outbreak, e.g. the reservoir, the route of transmission, the spectrum of disease and the reason for an unusual age��gender imbalance.

Authorities have employed strict control measures including closing live poultry markets and culling poultry in affected areas. Following these measures, the number of reported cases have dropped. It is not possible to determine at this point whether these two new cases, reported one week apart, mark the resurgence of the outbreak. ECDC��s earlier risk assessment remains valid.

EU citizens in China are strongly advised to avoid live bird markets. The risk of the disease spreading to Europe via humans is considered low. However, it is not unlikely that people presenting with severe respiratory infection in the EU and a history of potential exposure in the outbreak area will require investigation in Europe.


Actions

The Chinese health authorities continue to respond to this public health event with enhanced surveillance, epidemiological and laboratory investigation including scientific research.

ECDC is closely monitoring developments.

ECDC published an updated Rapid Risk Assessment on 8 May 2013.

A case detection algorithm and an EU case definition has been developed and shared with EU Member States.

ECDC guidance for Supporting diagnostic preparedness for detection of avian influenza A(H7N9) viruses in Europe for laboratories
was published on 24 April 2013.

(?)


-
------
 
Back
Top Bottom